SK282068B6 - Farmaceutický antikoncepčný prostriedok a jeho použitie - Google Patents

Farmaceutický antikoncepčný prostriedok a jeho použitie Download PDF

Info

Publication number
SK282068B6
SK282068B6 SK1013-95A SK101395A SK282068B6 SK 282068 B6 SK282068 B6 SK 282068B6 SK 101395 A SK101395 A SK 101395A SK 282068 B6 SK282068 B6 SK 282068B6
Authority
SK
Slovakia
Prior art keywords
antiprogestin
pharmaceutical
cycle
contraceptive
hydroxy
Prior art date
Application number
SK1013-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK101395A3 (en
Inventor
Gary D. Hodgen
Original Assignee
The Medical College Of Hampton Roads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Medical College Of Hampton Roads filed Critical The Medical College Of Hampton Roads
Publication of SK101395A3 publication Critical patent/SK101395A3/sk
Publication of SK282068B6 publication Critical patent/SK282068B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Fertilizers (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SK1013-95A 1993-02-19 1994-02-18 Farmaceutický antikoncepčný prostriedok a jeho použitie SK282068B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (2)

Publication Number Publication Date
SK101395A3 SK101395A3 (en) 1997-04-09
SK282068B6 true SK282068B6 (sk) 2001-10-08

Family

ID=21795040

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1013-95A SK282068B6 (sk) 1993-02-19 1994-02-18 Farmaceutický antikoncepčný prostriedok a jeho použitie

Country Status (24)

Country Link
US (1) US5516769A (de)
EP (2) EP0684825B1 (de)
JP (1) JP3054780B2 (de)
KR (1) KR100232833B1 (de)
AT (2) ATE286734T1 (de)
AU (1) AU692150B2 (de)
BG (1) BG62431B1 (de)
BR (1) BR9406666A (de)
CA (1) CA2156493C (de)
CZ (1) CZ294325B6 (de)
DE (2) DE69434239T2 (de)
DK (2) DK1159965T3 (de)
ES (1) ES2231356T3 (de)
FI (1) FI114687B (de)
HU (1) HU221162B1 (de)
NO (1) NO307916B1 (de)
NZ (1) NZ262998A (de)
PL (1) PL175440B1 (de)
PT (2) PT1159965E (de)
RO (1) RO118565B1 (de)
RU (1) RU2139055C1 (de)
SK (1) SK282068B6 (de)
UA (1) UA41351C2 (de)
WO (1) WO1994018982A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
PL353994A1 (en) 1999-08-31 2003-12-15 Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
PL310357A1 (en) 1995-12-11
HUT72079A (en) 1996-03-28
BG99867A (bg) 1996-04-30
HU221162B1 (en) 2002-08-28
PT1159965E (pt) 2005-03-31
UA41351C2 (uk) 2001-09-17
BR9406666A (pt) 1996-01-23
PL175440B1 (pl) 1998-12-31
NZ262998A (en) 1997-06-24
KR960700726A (ko) 1996-02-24
AU692150B2 (en) 1998-06-04
CA2156493A1 (en) 1994-09-01
NO307916B1 (no) 2000-06-19
DE69430732T2 (de) 2002-10-24
EP1159965A3 (de) 2002-05-22
FI114687B (fi) 2004-12-15
RO118565B1 (ro) 2003-07-30
ATE218347T1 (de) 2002-06-15
BG62431B1 (bg) 1999-11-30
PT684825E (pt) 2002-10-31
DK1159965T3 (da) 2005-05-23
DK0684825T3 (da) 2002-07-15
FI953878A0 (fi) 1995-08-17
KR100232833B1 (ko) 1999-12-01
CZ294325B6 (cs) 2004-11-10
JP3054780B2 (ja) 2000-06-19
JPH08510992A (ja) 1996-11-19
NO953242D0 (no) 1995-08-17
US5516769A (en) 1996-05-14
DE69430732D1 (de) 2002-07-11
ES2231356T3 (es) 2005-05-16
EP1159965A2 (de) 2001-12-05
ATE286734T1 (de) 2005-01-15
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
EP0684825A4 (de) 1998-01-14
WO1994018982A1 (en) 1994-09-01
EP1159965B1 (de) 2005-01-12
CA2156493C (en) 2002-10-29
AU6299294A (en) 1994-09-14
FI953878A (fi) 1995-08-17
RU2139055C1 (ru) 1999-10-10
NO953242L (no) 1995-08-17
EP0684825A1 (de) 1995-12-06
EP0684825B1 (de) 2002-06-05
SK101395A3 (en) 1997-04-09
CZ205095A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
US4855305A (en) Compositions and methods of effecting contraception utilizing melatonin
KR100385663B1 (ko) 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물
US7772219B2 (en) Methods of hormonal treatment utilizing extended cycle contraceptive regimens
JPH1129481A (ja) 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬
KR20120044307A (ko) 긴급 피임용 제약 조성물
US4670426A (en) Interruption of fertility in mammals by post-coital pills
Saunders Effects of sex steroids and related compounds on pregnancy and on development of the young.
US20030018018A1 (en) Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
SK282068B6 (sk) Farmaceutický antikoncepčný prostriedok a jeho použitie
NZ233697A (en) Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
Prasad Post-coital agents and menses inducing drugs
Darwash Effects of melengestrol acetate on postpartum reproductive activity of the dairy cow
JP2007197459A (ja) 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬
IL94411A (en) Compositions comprising an analog of melatonin in combination with progestogen and/or estrogen for effecting contraception

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20140218